Pfizer has signed a deal with Summit Therapeutics to assess the efficacy of Summit’s ivonescimab in combination with several ...
Celltrion has secured marketing authorisation from the EC for Avtozma, a biosimilar to Chugai Pharmaceutical’s RoActemra ...
MeiraGTx’s investigational gene therapy AAV-AIPL1 has improved the sight of 11 children who were born blind. MeiraGTx is ...
With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed – for now.
Teva Pharmaceuticals and Alvotech have announced the US launch of Selarsdi (ustekinumab-aekn) injection, a biosimilar to ...
Mirum Pharmaceuticals’ Ctexli (chenodiol) has gained US Food and Drug Administration (FDA) approval for treating adults with ...
While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...
The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer ...
The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive ...
Pfizer will end the global commercialisation of its haemophilia gene therapy Beqvez (fidanacogene elaparvovec) amid low ...
Product sales for the vaccine specialist Valneva reached €170m despite slow US sales of its chikungunya vaccine.
Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results